Form 4: SPX Technologies CEO Eugene Joseph Lowe III Reports Stock and Option Grants
SEC Filing Form 4
Eugene Joseph Lowe III, CEO of SPX Technologies, reports the acquisition of restricted stock units and stock options, as well as holdings in the 401(k) plan.
Summary
- Eugene Joseph Lowe III, the President and CEO of SPX Technologies, filed a Form 4 detailing changes in beneficial ownership.
- On March 3, 2025, Lowe acquired 28,535 shares of common stock through the grant of restricted stock units under the SPX 2019 Stock Compensation Plan.
- Lowe also acquired 21,529 stock options with an exercise price of $138.60, vesting in three equal installments beginning March 3, 2026, and expiring on March 3, 2035.
- The filing also indicates Lowe's existing holdings, including 773,072 shares of common stock (including unvested restricted stock units) and 5,000 shares held indirectly through a 401(k) plan.
- Additionally, Lowe holds multiple employee stock options granted between 2020 and 2027 with varying exercise prices and expiration dates.
Sentiment
Score: 5
Explanation: The document is a neutral report of stock and option grants, with no inherent positive or negative sentiment.
Positives
- The grant of restricted stock units and stock options to the CEO aligns his interests with those of the shareholders.
- The vesting schedules of the stock options encourage long-term commitment from the CEO.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Investors monitor these filings to gain insights into management's perspective on the company's stock.
Stakeholder Impact
- The stock and option grants may incentivize the CEO to improve company performance, benefiting shareholders.
- The grants represent a form of compensation for the CEO, impacting the company's overall expenses.
Key Dates
| Date | Description |
|---|---|
| 03/01/2020 | Grant date of employee stock options with an exercise price of $27.40, vesting in three equal installments beginning on March 1, 2018, and expiring on March 1, 2027. |
| 02/22/2021 | Grant date of employee stock options with an exercise price of $32.69, vesting in three equal installments beginning on February 22, 2019, and expiring on February 22, 2028. |
| 02/21/2022 | Grant date of employee stock options with an exercise price of $36.51, vesting in three equal installments beginning on February 21, 2020, and expiring on February 21, 2029. |
| 02/20/2023 | Grant date of employee stock options with an exercise price of $50.09, vesting in three equal installments beginning on February 20, 2021, and expiring on February 20, 2030. |
| 03/01/2024 | Grant date of employee stock options with an exercise price of $58.34, vesting in three equal installments beginning on March 1, 2022, and expiring on March 1, 2031. |
| 03/01/2025 | Grant date of employee stock options with an exercise price of $48.97, vesting in three equal installments beginning on March 1, 2023, and expiring on March 1, 2032. |
| 03/01/2025 | Grant date of employee stock options with an exercise price of $71.93, vesting in three equal installments beginning on March 1, 2024, and expiring on March 1, 2033. |
| 03/03/2025 | Date of transaction: Grant of restricted stock units and stock options. |
| 02/28/2027 | Grant date of employee stock options with an exercise price of $116.40, vesting in three equal installments beginning on February 28, 2025, and expiring on February 28, 2034. |
| 03/01/2026 | Grant date of employee stock options with an exercise price of $71.93, vesting in three equal installments beginning on March 1, 2024, and expiring on March 1, 2033. |
| 03/03/2026 | First vesting date for the stock options granted on March 3, 2025. |
| 03/01/2027 | Expiration date for the employee stock options granted on March 1, 2020. |
| 02/22/2028 | Expiration date for the employee stock options granted on February 22, 2021. |
| 02/21/2029 | Expiration date for the employee stock options granted on February 21, 2022. |
| 02/20/2030 | Expiration date for the employee stock options granted on February 20, 2023. |
| 03/01/2031 | Expiration date for the employee stock options granted on March 1, 2024. |
| 03/01/2032 | Expiration date for the employee stock options granted on March 1, 2025. |
| 03/01/2033 | Expiration date for the employee stock options granted on March 1, 2026. |
| 02/28/2034 | Expiration date for the employee stock options granted on February 28, 2027. |
| 03/03/2035 | Expiration date for the stock options granted on March 3, 2025. |
Keywords
SPX Technologies, Eugene Joseph Lowe III, Form 4, Stock Options, Restricted Stock Units, Beneficial Ownership, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.